Antimicrobial resistance among clinical Enterobacterales isolated from humans in Senegal: a systematic review and meta-analysis from 1987 to 2022. [PDF]
Dossouvi KM +7 more
europepmc +1 more source
Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]
Nuaimi M +6 more
europepmc +1 more source
Inference of ceftobiprole susceptibility through surrogate testing of ceftaroline. [PDF]
Sader HS +4 more
europepmc +1 more source
<i>In vitro</i> activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023. [PDF]
Lee Y-L +5 more
europepmc +1 more source
Predominance of antimicrobial resistance genes and high-risk clones among Gram negatives from clinical sources in Accra-Ghana. [PDF]
Boateng W +8 more
europepmc +1 more source
Epidemiology of ESBL-Producing, Carbapenem-Resistant, and Carbapenemase-Producing Enterobacterales in Southern Africa. [PDF]
Ntshonga P, Paganotti GM, Gaibani P.
europepmc +1 more source
Risk factors, and outcomes of patients with carbapenem-resistant Enterobacterales bloodstream infection: an eight-year case-case-control study. [PDF]
Kong H +10 more
europepmc +1 more source
A public health risk model using prior healthcare exposures identifies healthcare-associated pathogen carriage. [PDF]
Sansom SE +9 more
europepmc +1 more source
High <i>in vitro</i> activity of aztreonam/avibactam against NDM-producing Enterobacterales with emerging resistance in <i>Escherichia coli</i> in the United States Mid-Atlantic region. [PDF]
Eklund E +11 more
europepmc +1 more source

